Synovitis

Ultrasound Case: Transient Synovitis
http://www.hss.edu/

Ankle Injuries sprains…and the sprain that wasn’t
Jonathan A. Drezner, MD
http://staff.washington.edu

Evaluation of the Child with a Limp
DD Aronsson
http://www.med.uvm.edu

Joints (arthritis) – Rheumatoid arthritis
http://www.itc.csmd.edu/

Morbidity and Mortality Conference
Jennifer Y. Lee
http://geiselmed.dartmouth.edu

Chronic Osteomyelitis - Factors responsible for chronicity
http://www.nmcth.edu

The Child With Joint Pain - Diagnostic Clues
Abraham Gedalia, M.D.
http://www.medschool.lsuhsc.edu

Rheumatoid Arthritis
Praharsha R. Menon
http://www.fpm.emory.edu

Common Athletic Injuries
http://www.longwood.edu

Mixed Connective Tissue Disease
Still Crazy, Christina Kahl
http://www.med.unc.edu

Hip pathology
http://peds.stanford.edu

Overview of Rheumatoid Arthritis
Naureen Mirza, MD
https://cbase.som.sunysb.edu

The Limping Child
Wendalyn King MD, MPH
http://www.pediatrics.emory.edu

Limp and Joint Pain
Sushma Penmetsa, Carrie De Moor
http://www.utmb.edu

Clinical Approach to Acute Arthritis
Yolanda Farhey, MD
http://www.med.uc.edu

434 free full text ublished articles

1. Impact of intravenous abatacept on synovitis, osteitis and structural damage in patients with rheumatoid arthritis and an inadequate response to methotrexate: the ASSET randomised controlled trial.
2. Assessment of synovitis to predict bone erosions in rheumatoid arthritis.
3. Diffusion-weighted MRI of bone marrow oedema, soft tissue oedema and synovitis in paediatric patients: feasibility and initial experience.
4. The ability of synovitis to predict structural damage in rheumatoid arthritis: a comparative study between clinical examination and ultrasound.
5. Evidence of the symptomatic and structural efficacy of methotrexate in daily practice as the first disease-modifying drug in rheumatoid arthritis despite its suboptimal use: results from the ESPOIR early synovitis cohort.
6. Low-dose external beam radiotherapy as a postoperative treatment for patients with diffuse pigmented villonodular synovitis of the knee: 4 recurrences in 23 patients followed for mean 9 years.
7. Remitting seronegative symmetrical synovitis with pitting edema syndrome in a chronic hemodialysis patient.
8. Chronic mandibular osteomyelitis with suspected underlying synovitis, acne, pustulosis, hyperostosis, and osteitis (SAPHO) syndrome: a case report.
9. Milwaukee shoulder syndrome associated with pigmented villonodular synovitis. Case report.
10. Serum levels of CXCL13 are associated with ultrasonographic synovitis and predict power Doppler persistence in early rheumatoid arthritis treated with non-biological disease-modifying anti-rheumatic drugs.
11. Synovitis in spondyloarthritides.
12. Remmiting symmetric seronegative synovitis with pitting edema (RS3PE).
13. [Diffuse pigmented villonodular synovitis in the shoulder joint and the biceps tendon: a case report].
14. Interleukin 34 expression is associated with synovitis severity in rheumatoid arthritis patients.
15. The soluble biomarker calprotectin (a S100 protein) is associated to ultrasonographic synovitis scores and is sensitive to change in patients with rheumatoid arthritis treated with adalimumab.
16. Cerebral activation during unilateral clenching in patients with temporomandibular joint synovitis and biting pain: an functional magnetic resonance imaging study.
17. Binding immunoglobulin protein resolves rheumatoid synovitis: a xenogeneic study using rheumatoid arthritis synovial membrane transplants in SCID mice.
18. Pigmented villonodular synovitis of the hip in systemic lupus erythematosus: a case report.
19. Long-term results of surgical treatment of pigmented villonodular synovitis of the knee.
20. Tibial torus and toddler's fractures misdiagnosed as transient synovitis: a case series.
21. Epidural analgesia with morphine or buprenorphine in ponies with lipopolysaccharide (LPS)-induced carpal synovitis.
22. Ultrasound in rheumatoid arthritis: volar versus dorsal synovitis evaluation and scoring.
23. Pigmented villonodular synovitis responsive to imatinib therapy.
24. Hemiarthroplasty for pigmented villonodular synovitis of the shoulder: a report of two cases.
25. Synovitis in psoriatic arthritis: immunohistochemistry, comparisons with rheumatoid arthritis, and effects of therapy.
26. Pigmented villonodular synovitis of the knee in skeletally immature patients.
27. The rate of polymyalgia rheumatica (PMR) and remitting seronegative symmetrical synovitis with pitting edema (RS3PE) syndrome in a clinic where primary care physicians are working in Japan.
28. Fluctuation of knee pain and changes in bone marrow lesions, effusions, and synovitis on magnetic resonance imaging.
29. Platelets participate in synovitis via Cox-1-dependent synthesis of prostacyclin independently of microparticle generation.
30. Change in CD3 positive T-cell expression in psoriatic arthritis synovium correlates with change in DAS28 and magnetic resonance imaging synovitis scores following initiation of biologic therapy--a single centre, open-label study.
31. Malignant pigmented villonodular synovitis in the knee - report of a case with rapid clinical progression.
32. Effects of hyaluronan on carrageenan-induced synovitis in rat TMJ.
33. Neoangiogenesis contributes to the development of hemophilic synovitis.
34. Expression of β-1,4-galactosyltransferase I in a surgically-induced rat model of knee osteoarthritic synovitis.
35. A case of villonodular synovitis of the shoulder in an adolescent: imaging and pathologic diagnosis.
36. Utility of ultrasound joint counts in the prediction of rheumatoid arthritis in patients with very early synovitis.
37. The role of synovitis in osteoarthritis.
38. Remitting seronegative symmetrical synovitis with pitting oedema syndrome, associated with prostate adenocarcinoma: a case report.
39. Longitudinal assessment of cyst-like lesions of the knee and their relation to radiographic osteoarthritis and MRI-detected effusion and synovitis in patients with knee pain.
40. [Pseudotumoral villonodular synovitis : a case report].
41. An unusual cause of recurrent joint effusions: nonhemophilic hemosiderotic synovitis of the knee.
42. [Differentiation between transient synovitis and septic arthritis of the hip with clinical and ultrasound criteria].
43. [Pigmented villonodular synovitis in children].
44. [Treatment resistant chronic monoarticular synovitis: Lipoma arborescens].
45. Clinical images: Synovitis on magnetic resonance imaging; osteochondromatosis at hip arthroscopy.
46. MRI of macrophages in infectious knee synovitis.
47. Early reactive synovitis and osteolysis after total hip arthroplasty.
48. Pigmented villonodular synovitis of the spine: report of a lumbar case.
49. [Establishment of animal model of temporomandibular joint synovitis and its histological investigation].
50. Angiogenesis and the persistence of inflammation in a rat model of proliferative synovitis.
51. Subclinical synovitis in primary Sjögren's syndrome: an ultrasonographic study.
52. Response of symptoms and synovitis to intra-muscular methylprednisolone in osteoarthritis of the hand: an ultrasonographic study.
53. Differing effects of exogenous and endogenous hydrogen sulphide in carrageenan-induced knee joint synovitis in the rat.
54. Pigmented villonodular synovitis of the knee in a patient on oral anticoagulation therapy: a case report.
55. A rare case of pigmented villonodular synovitis after unicompartmental knee replacement: a case report.
56. Metallosis and Metal-Induced Synovitis Following Total Knee Arthroplasty: Review of Radiographic and CT Findings.
57. FDG uptake in sternoclavicular joint synovitis: mimic of internal mammary adenopathy.
58. Effectiveness of radiation synovectomy with samarium-153 particulate hydroxyapatite in rheumatoid arthritis patients with knee synovitis: a controlled randomized double-blind trial.
59. Treatment of a patient with remitting seronegative, symmetrical synovitis with pitting oedema with a humanized anti-interleukin-6 receptor antibody, tocilizumab.
60. The detection of subclinical synovitis by ultrasound in oligoarticular juvenile idiopathic arthritis: a pilot study.
61. Adiponectin may contribute to synovitis and joint destruction in rheumatoid arthritis by stimulating vascular endothelial growth factor, matrix metalloproteinase-1, and matrix metalloproteinase-13 expression in fibroblast-like synoviocytes more than proinflammatory mediators.
62. Comparison of clinical versus ultrasound-determined synovitis in juvenile idiopathic arthritis.
63. Gadd45beta deficiency in rheumatoid arthritis: enhanced synovitis through JNK signaling.
64. [Juvenile idiopathic arthritis with dry synovitis: clinical case and review of literature].
65. Outcomes after excision of pigmented villonodular synovitis of the knee.
66. Clinical and radiologic evolution of synovitis, acne, pustulosis, hyperostosis, and osteitis syndrome: a single center study of a cohort of 71 subjects.
67. Hoffa's Fat Pad: Evaluation on Unenhanced MR Images as a Measure of Patellofemoral Synovitis in Osteoarthritis.
68. Inhibitory effect of CD147/HAb18 monoclonal antibody on cartilage erosion and synovitis in the SCID mouse model for rheumatoid arthritis.
69. Pigmented villonodular synovitis in both hindfeet.
70. Pigmented villonodular synovitis of the elbow with a fenestrated fossa: a case report.
71. Tuberculous synovitis in a HIV positive patient.
72. The differential expressions of 78-kDa glucose-regulated protein of infiltrating plasma cells in peripheral joints with the histopathological variants of rheumatoid synovitis.
73. Treatment of diffuse pigmented villonodular synovitis of the knee with combined surgical and radiosynovectomy.
74. An ultrasonographic study of osteoarthritis of the hand: synovitis and its relationship to structural pathology and symptoms.
75. Noninvasive imaging of macrophages in rheumatoid synovitis using 11C-(R)-PK11195 and positron emission tomography.
76. Diagnosis of remitting seronegative symmetrical synovitis with pitting edema in a patient with sarcoidosis: comment on the article by Dejaco et al.
77. Pigmented villonodular synovitis.
78. Pigmented villonodular synovitis: radiologic-pathologic correlation.
79. Case report: subacute synovitis of the knee after a rose thorn injury: unusual clinical picture.
80. Intraarticular factor IX protein or gene replacement protects against development of hemophilic synovitis in the absence of circulating factor IX.
81. Anti-collagen type II antibodies in patients with very early synovitis.
82. B lymphocyte autoimmunity in rheumatoid synovitis is independent of ectopic lymphoid neogenesis.
83. Characterization of the immune response in the synovitis, acne, pustulosis, hyperostosis, osteitis (SAPHO) syndrome.
84. Anti-cyclic citrullinated peptide antibodies in primary Sjögren syndrome may be associated with non-erosive synovitis.
85. Complete response to imatinib in relapsing pigmented villonodular synovitis/tenosynovial giant cell tumor (PVNS/TGCT).
86. Gouty synovitis after total knee arthroplasty: a case report.
87. Bullet-induced synovitis as a cause of secondary osteoarthritis of the hip joint: A case report and review of literature.
88. Monitoring rheumatoid arthritis synovitis with 99mTc-anti-CD3.
89. Histopathologic changes at "synovio-entheseal complexes" suggesting a novel mechanism for synovitis in osteoarthritis and spondylarthritis.
90. Pigmented villonodular synovitis in children: a report of six cases and review of the literature.
91. Absence of histologic evidence of synovitis in patients with Gulf War veterans' illness with joint pain.
92. Three-dimensional power Doppler sonography in short-term therapy monitoring of rheumatoid synovitis.
93. Septic arthritis versus transient synovitis of the hip: gadolinium-enhanced MRI finding of decreased perfusion at the femoral epiphysis.
94. Remitting seronegative symmetrical synovitis with pitting edema (RS3PE) syndrome accompanied by Parkinson's disease.
95. Pigmented villonodular synovitis originating from the lumbar facet joint: a case report.
96. Remitting seronegative symmetrical synovitis with pitting oedema associated with lung malignancy.
97. Synovitis detected on magnetic resonance imaging and its relation to pain and cartilage loss in knee osteoarthritis.
98. Pigmented villonodular synovitis of the elbow in a 6-year-old girl: a case report.
99. Pigmented villonodular synovitis with chondroid metaplasia, resembling chondroblastoma of the bone: a report of three cases.
100. Angiotensin II type 1 receptor as a novel therapeutic target in rheumatoid arthritis: in vivo analyses in rodent models of arthritis and ex vivo analyses in human inflammatory synovitis.
101. Power Doppler sonography and pulse-inversion harmonic imaging in evaluation of rheumatoid arthritis synovitis.
102. [Intra-articular treatment with the TNF-alpha antagonist, etanercept, in severe diffuse pigmented villonodular synovitis of the knee].
103. Presence of significant synovitis in rheumatoid arthritis patients with disease-modifying antirheumatic drug-induced clinical remission: evidence from an imaging study may explain structural progression.
104. Remitting seronegative symmetrical synovitis with pitting edema syndrome: followup for neoplasia.
105. Clinical image: pigmented villonodular synovitis of the knee.
106. Diagnostic quality and scoring of synovitis, tenosynovitis and erosions in low-field MRI of patients with rheumatoid arthritis: a comparison with conventional MRI.
107. Atorvastatine for chronic synovitis due to massive intra-articular cholesterol monohydrate deposition in long-standing rheumatoid arthritis.
108. Leukaemic synovitis.
109. A comparison of clinical vs ultrasound determined synovitis in rheumatoid arthritis utilizing gray-scale, power Doppler and the intravenous microbubble contrast agent 'Sono-Vue'.
110. Role of radiofrequency denervation in lumbar zygapophyseal joint synovitis in baseball pitchers: a clinical experience.
111. Conundrums in nosology: synovitis, acne, pustulosis, hyperostosis, and osteitis syndrome and spondylarthritis.
112. [A case of pigmented villonodular synovitis of the elbow joint with bone invasion].
113. Power Doppler ultrasonography and synovitis: correlating ultrasound imaging with histopathological findings and evaluating the performance of ultrasound equipments.
114. Diffuse pigmented villonodular synovitis of the foot and ankle treated with surgery and radiotherapy.
115. Acetaminophen, like conventional NSAIDs, may reduce synovitis in osteoarthritic knees.
116. Pigmented villonodular synovitis of the hip mimicking soft-tissue sarcoma: a case report.
117. Analysis of pigmented villonodular synovitis with genome-wide complementary DNA microarray and tissue array technology reveals insight into potential novel therapeutic approaches.
118. MRI for differentiating ganglion and synovitis in the chronic painful wrist.
119. Effects of repetitive shortwave diathermy for reducing synovitis in patients with knee osteoarthritis: an ultrasonographic study.
120. Immunomodulatory effects of etanercept on peripheral joint synovitis in the spondylarthropathies.
121. Spontaneous development of synovitis and cartilage degeneration in transgenic mice overexpressing cathepsin K.
122. Molecular markers of cartilage breakdown and synovitis at baseline as predictors of structural progression of hip osteoarthritis. The ECHODIAH Cohort.
123. [Psoriatic synovitis: pathogenic and therapeutic implications].
124. Cytokinin panel in rheumatoid arthritis and correlation with histological patterns of synovitis -- active type of disease.
125. Remitting seronegative symmetrical synovitis with pitting oedema/polymyalgia rheumatica after infection with Mycoplasma pneumoniae.
126. Trypsin-2 degrades human type II collagen and is expressed and activated in mesenchymally transformed rheumatoid arthritis synovitis tissue.
127. The validation of simple scoring methods for evaluating compartment-specific synovitis detected by MRI in knee osteoarthritis.
128. Requirement of IL-17 receptor signaling in radiation-resistant cells in the joint for full progression of destructive synovitis.
129. [Reactive synovitis: MRI features with arthroscopic correlation].
130. Further evidence that a cartilage-pannus junction synovitis predilection is not a specific feature of rheumatoid arthritis.
131. Reactive carpal synovitis: initial experience with MR imaging.
132. Characterization of histopathology and gene-expression profiles of synovitis in early rheumatoid arthritis using targeted biopsy specimens.
133. B cells in rheumatoid synovitis.
134. Remitting seronegative symmetrical synovitis with pitting edema of the hands: ultrasound, color doppler ultrasound, and magnetic resonance imaging findings.
135. Involvement of neurotrophins and their receptors in spondyloarthritis synovitis: relation to inflammation and response to treatment.
136. Multifocal pigmented villonodular synovitis in a child.
137. Role of osteopontin in amplification and perpetuation of rheumatoid synovitis.
138. A novel ultrasonographic synovitis scoring system suitable for analyzing finger joint inflammation in rheumatoid arthritis.
139. Osteolysis with detritic synovitis: appearance in a patient with connective tissue disease.
140. Fibroblast-like synoviocytes derived from patients with rheumatoid arthritis show the imprint of synovial tissue heterogeneity: evidence of a link between an increased myofibroblast-like phenotype and high-inflammation synovitis.
141. [What is your diagnosis? Pigmented villonodular synovitis of the knee].
142. Recurrent hemarthrosis of the knee mimicking pigmented villonodular synovitis.
143. Optimised, low cost, low field dedicated extremity MRI is highly specific and sensitive for synovitis and bone erosions in rheumatoid arthritis wrist and finger joints: comparison with conventional high field MRI and radiography.
144. Conspicuous synovial lymphatic capillaries in juvenile idiopathic arthritis synovitis with rice bodies.
145. Very early treatment with infliximab in addition to methotrexate in early, poor-prognosis rheumatoid arthritis reduces magnetic resonance imaging evidence of synovitis and damage, with sustained benefit after infliximab withdrawal: results from a twelve-month randomized, double-blind, placebo-controlled trial.
146. Synovitis induced by alendronic acid can present as acute carpal tunnel syndrome.
147. Increased expression of humanin peptide in diffuse-type pigmented villonodular synovitis: implication of its mitochondrial abnormality.
148. Rheumatoid and psoriatic knee synovitis: clinical, grey scale, and power Doppler ultrasound assessment of the response to etanercept.
149. Regulation of the symmetry and intensity of immune complex-mediated synovitis by nuclear factor of activated T cells.
150. Involvement of matrix metalloproteinases and their inhibitors in peripheral synovitis and down-regulation by tumor necrosis factor alpha blockade in spondylarthropathy.
151. Detection of small joint synovitis by ultrasonography: the learning curve of rheumatologists.
152. Central role of complement membrane attack complex in monosodium urate crystal-induced neutrophilic rabbit knee synovitis.
153. Regional variation and differential response to therapy for knee synovitis adjacent to the cartilage-pannus junction and suprapatellar pouch in inflammatory arthritis: implications for pathogenesis and treatment.
154. Tumour necrosis factor alpha blockade in treatment resistant pigmented villonodular synovitis.
155. First clinical evaluation of sagittal laser optical tomography for detection of synovitis in arthritic finger joints.
156. Pathobiology of hemophilic synovitis I: overexpression of mdm2 oncogene.
157. Association of CD163+ macrophages and local production of soluble CD163 with decreased lymphocyte activation in spondylarthropathy synovitis.
158. Comparison of ultrasonographic assessment of synovitis and joint vascularity with radiographic evaluation in a randomized, placebo-controlled study of infliximab therapy in early rheumatoid arthritis.
159. Magnetic resonance imaging of wrist and finger joints in healthy subjects occasionally shows changes resembling erosions and synovitis as seen in rheumatoid arthritis.
160. Intra-articular methotrexate in knee synovitis.
161. Sonography and subclinical synovitis.
162. Detection of major histocompatibility complex/human cartilage gp-39 complexes in rheumatoid arthritis synovitis as a specific and independent histologic marker.
163. Validation and reproducibility of ultrasonography in the detection of synovitis in the knee: a comparison with arthroscopy and clinical examination.
164. Combined effect of bradykinin B2 and neurokinin-1 receptor activation on endothelial cell proliferation in acute synovitis.
165. MR imaging features of pigmented villonodular synovitis of the cervical spine.
166. Power Doppler ultrasound of rheumatoid synovitis: quantification of therapeutic response.
167. Membrane-associated IL-1 contributes to chronic synovitis and cartilage destruction in human IL-1 alpha transgenic mice.
168. Sjögren's syndrome presenting as remitting seronegative symmetric synovitis with pitting edema (RS3PE): comment of the article by Choi et al.
169. A fibrin based model for rheumatoid synovitis.
170. New strategies to control inflammatory synovitis: interleukin 15 and beyond.
171. A prospective, clinical and radiological study of early psoriatic arthritis: an early synovitis clinic experience.
172. Deficiency of NADPH oxidase components p47phox and gp91phox caused granulomatous synovitis and increased connective tissue destruction in experimental arthritis models.
173. Randomised controlled study of postinjection immobilisation after intra-articular glucocorticoid treatment for wrist synovitis.
174. Rheumatoid hand joint synovitis: gray-scale and power Doppler US quantifications following anti-tumor necrosis factor-alpha treatment: pilot study.
175. Sjogren's syndrome presenting as remitting seronegative symmetric synovitis with pitting edema (RS3PE).
176. Synoviocyte-mediated expansion of inflammatory T cells in rheumatoid synovitis is dependent on CD47-thrombospondin 1 interaction.
177. Localised pigmented villonodular synovitis: an uncommon cause of knee pain mimicking a meniscal tear.
178. Localized nodular synovitis of the knee: MR imaging appearance and clinical correlates in 21 patients.
179. Diagnostic points and possible origin of osteomyelitis in synovitis, acne, pustulosis, hyperostosis and osteitis (SAPHO) syndrome: a radiographic study of 77 mandibular osteomyelitis cases.
180. Role of metacarpophalangeal joint anatomic factors in the distribution of synovitis and bone erosion in early rheumatoid arthritis.
181. Advanced glycation end-product (AGE)-damaged IgG and IgM autoantibodies to IgG-AGE in patients with early synovitis.
182. Circulating tumour necrosis factor alpha and soluble tumour necrosis factor receptors in patients with different patterns of rheumatoid synovitis.
183. Musculoskeletal images. Silicone synovitis.
184. Elucidation of the relationship between synovitis and bone damage: a randomized magnetic resonance imaging study of individual joints in patients with early rheumatoid arthritis.
185. [Seven cases of remitting seronegative symmetrical synovitis with pitting edema (RS3PE) syndrome].
186. Infrared spectroscopy: shedding light on synovitis in patients with rheumatoid arthritis.
187. Unmasking the anti-inflammatory cytokine response in rheumatoid synovitis.
188. Importance of T cells in rheumatoid synovitis: comment on the review by Firestein and Zvaifler.
189. Remitting seronegative symmetrical synovitis with pitting oedema as the first manifestation of psoriatic arthropathy.
190. High mobility group box chromosomal protein 1: a novel proinflammatory mediator in synovitis.
191. The use of surgery and yttrium 90 in the management of extensive and diffuse pigmented villonodular synovitis of large joints.
192. Arthroscopy and psoriatic knee joint synovitis.
193. Diagnosis please. Case 50: primary coccidioidal synovitis of the knee.
194. In vivo activated T cells in rheumatoid synovitis. Analysis of Th1- and Th2-type cytokine production at clonal level in different stages of disease.
195. Soluble adhesion molecules (ICAM-1, VCAM-1, and E-selectin) and vascular endothelial growth factor (VEGF) in patients with distinct variants of rheumatoid synovitis.
196. c-myc proto-oncogene expression in hemophilic synovitis: in vitro studies of the effects of iron and ceramide.
197. Protoporphyrin IX photodynamic therapy for synovitis.
198. [Role of chemokines in the pathogenesis of chronic synovitis during rheumatoid arthritis].
199. CD8 T cells are required for the formation of ectopic germinal centers in rheumatoid synovitis.
200. High-dose cyclophosphamide with stem cell rescue for severe rheumatoid arthritis: short-term efficacy correlates with reduction of macroscopic and histologic synovitis.
201. Foreign body synovitis induced by a crown-of-thorns starfish.
202. Increased matrix metalloproteinase-3 serum levels in rheumatic diseases: relationship with synovitis and steroid treatment.
203. Serum matrix metalloproteinases and tissue inhibitors of metalloproteinases in different histological variants of rheumatoid synovitis.
204. Power Doppler ultrasonography for assessment of synovitis in the metacarpophalangeal joints of patients with rheumatoid arthritis: a comparison with dynamic magnetic resonance imaging.
205. Referrals to an "early synovitis clinic": are they appropriate?
206. Interleukin-1-induced subacromial synovitis and shoulder pain in rotator cuff diseases.
207. Lymphoid neogenesis in rheumatoid synovitis.
208. Can rheumatologists agree on a diagnosis of inflammatory arthritis in an early synovitis clinic?
209. Recurring synovitis as a possible reason for aseptic loosening of knee endoprostheses in patients with rheumatoid arthritis.
210. Cytokines and cellular interactions in inflammatory synovitis.
211. Remitting seronegative symmetrical synovitis with pitting oedema (RS3PE) as recurrence of aborted PMR.
212. Case of synovitis potentially caused by Dolosigranulum pigrum.
213. Cell-cell interactions in synovitis: antigen presenting cells and T cell interaction in rheumatoid arthritis.
214. Quantitative magnetic resonance imaging as marker of synovial membrane regeneration and recurrence of synovitis after arthroscopic knee joint synovectomy: a one year follow up study.
215. CD30+ T cells in rheumatoid synovitis: mechanisms of recruitment and functional role.
216. Esophageal carcinoma presenting as seronegative symmetrical synovitis with pitting edema.
217. Cell-cell interactions in synovitis. Interactions between T cells and B cells in rheumatoid arthritis.
218. Cell-cell interactions in synovitis. Interactions between T lymphocytes and synovial cells.
219. Cell-cell interactions in synovitis. Endothelial cells and immune cell migration.
220. The challenge of early synovitis: multiple pathways to a common clinical syndrome.
221. Cytokines and direct cell contact in synovitis: relevance to therapeutic intervention.
222. Current perspectives on synovitis.
223. Do B cells influence disease progression in chronic synovitis? Lessons from primary hypogammaglobulinaemia.
224. Active synovial matrix metalloproteinase-2 is associated with radiographic erosions in patients with early synovitis.
225. Rheumatoid arthritis associated autoantibodies in patients with synovitis of recent onset.
226. Intraarticular osteoid osteoma associated with synovitis: a possible role of cyclooxygenase-2 expression by osteoblasts in the nidus.
227. Reliability and sensitivity to change of various measures of hand function in relation to treatment of synovitis of the metacarpophalangeal joint in rheumatoid arthritis.
228. Radiolabelled interleukin-1 receptor antagonist for detection of synovitis in patients with rheumatoid arthritis.
229. A case report of synovitis, acne, pustulosis, hyperostosis and osteitis syndrome presenting with spondylodiscitis.
230. A 1-year follow-up study of dynamic magnetic resonance imaging in early rheumatoid arthritis reveals synovitis to be increased in shared epitope-positive patients and predictive of erosions at 1 year.
231. Adrenocorticotropin, glucocorticoid, and androgen secretion in patients with new onset synovitis/rheumatoid arthritis: relations with indices of inflammation.
232. Localized pigmented villonodular synovitis of the knee joint: neoplasm or reactive granuloma? A review of 18 cases.
233. Pigmented villonodular synovitis and giant cell tumors of the tendon sheath: radiologic and pathologic features.
234. Pigmented villonodular synovitis of the hip and knee.
235. Synovitis of small joints: sonographic guided diagnostic and therapeutic approach.
236. Double blind glucocorticoid controlled trial of samarium-153 particulate hydroxyapatite radiation synovectomy for chronic knee synovitis.
237. Influence of radiation synovectomy on articular cartilage, synovial thickness and enhancement as evidenced by MRI in patients with chronic synovitis.
238. Association of HLA alleles and clinical features in patients with synovitis of recent onset.
239. The relationship between synovitis and bone changes in early untreated rheumatoid arthritis: a controlled magnetic resonance imaging study.
240. Can HLA-DR explain the varying frequency of synovitis in polymyalgia rheumatica? Comment on the article by Salvarani et al.
241. Distinct vascular patterns of early synovitis in psoriatic, reactive, and rheumatoid arthritis.
242. An unusual case of pigmented villonodular synovitis of the spine: benign aggressive and/or malignant?
243. Remitting seronegative symmetrical synovitis with pitting oedema (RS3PE) syndrome: a prospective follow up and magnetic resonance imaging study.
244. Changes in articular synovial lining volume measured by magnetic resonance in a randomized, double-blind, controlled trial of intra-articular samarium-153 particulate hydroxyapatite for chronic knee synovitis.
245. Finger joint synovitis in rheumatoid arthritis: quantitative assessment by magnetic resonance imaging.
246. Septic arthritis versus transient synovitis at MR imaging: preliminary assessment with signal intensity alterations in bone marrow.
247. Diagnostic evaluation of classification criteria for rheumatoid arthritis and reactive arthritis in an early synovitis outpatient clinic.
248. Different mechanisms of synovial hyperplasia in rheumatoid arthritis and pigmented villonodular synovitis: the role of telomerase activity in synovial proliferation.
249. Anterior joint capsule of the normal hip and in children with transient synovitis: US study with anatomic and histologic correlation.
250. IL-16 as an anti-inflammatory cytokine in rheumatoid synovitis.
251. Influence of hypoxia in inflammatory synovitis.
252. Pigmented villonodular synovitis of the temporomandibular joint: diagnostic imaging and endovascular therapeutic embolization of a rare head and neck tumor.
253. Pigmented villonodular synovitis and related lesions: the spectrum of imaging findings.
254. Septic synovitis and arthritis due to Corynebacterium striatum following an accidental scalpel injury.
255. Monoarticular chronic synovitis in a child.
256. The role of CD8+ CD40L+ T cells in the formation of germinal centers in rheumatoid synovitis.
257. The hemagglutination-positive phenotype of Mycoplasma synoviae induces experimental infectious synovitis in chickens more frequently than does the hemagglutination-negative phenotype.
258. Cytokine and matrix metalloproteinase expression in pigmented villonodular synovitis may mediate bone and cartilage destruction.
259. Spontaneous synovitis in Wistar rats.
260. [The synovitis-acne-pustulosis-hyperostosis-osteitis (SAPHO) syndrome, a rare extra-digestive manifestation of Crohn's disease. Presentation of 1 case and review of the literature].
261. CD134/OX40 expression by synovial fluid CD4+ T lymphocytes in chronic synovitis.
262. Disseminated Mycobacterium avium complex infection associated with bifocal synovitis in a patient with dermatomyositis.
263. Measurement of synovial lining volume by magnetic resonance imaging of the knee in chronic synovitis.
264. Tissue cytokine patterns distinguish variants of rheumatoid synovitis.
265. Midkine, a retinoic acid-inducible heparin-binding cytokine in inflammatory responses: chemotactic activity to neutrophils and association with inflammatory synovitis.
266. Persistent synovitis treated with radiation synovectomy using yttrium-90: a retrospective evaluation of 83 procedures for 45 patients.
267. Giant cells in pigmented villo nodular synovitis express an osteoclast phenotype.
268. Multiple mechanisms support oligoclonal T cell expansion in rheumatoid synovitis.
269. Gelatinase B in chronic synovitis: immunolocalization with a monoclonal antibody.
270. Antiperinuclear factor in early synovitis.
271. Pigmented villonodular synovitis.
272. Methylobacterium mesophilicum synovitis in an alcoholic.
273. Synovitis associated with an electrical injury.
274. Multinucleated cells in pigmented villonodular synovitis and giant cell tumor of tendon sheath express features of osteoclasts.
275. The relationship between synovitis and erosions in rheumatoid arthritis.
276. Pigmented villonodular synovitis arising from the subtalar joint: a case report.
277. The Michael Mason Prize Essay 1996. Role of adhesion mechanisms in the pathogenesis of chronic synovitis.
278. Eosinophilic synovitis.
279. Arthroscopic synovectomy in rheumatoid and psoriatic knee joint synovitis: long-term outcome.
280. Persistent synovial fistula after arthroscopy: is titanium synovitis a risk factor?
281. Long-term sonographic follow-up of rheumatoid and psoriatic proliferative knee joint synovitis.
282. Eosinophilic synovitis.
283. Inflammatory microcrystals differentially regulate the secretion of macrophage inflammatory protein 1 and interleukin 8 by human neutrophils: a possible mechanism of neutrophil recruitment to sites of inflammation in synovitis.
284. Rabbit polymorphonuclear granulocyte function during ethanol administration--migration and oxidative responses in a joint with immune complex synovitis.
285. Progression from simple joint effusion to extensive pigmented villonodular synovitis of the hip within 2 years: demonstration with MR imaging.
286. Polymyalgia rheumatica and giant cell arteritis. Synovitis and polymyalgia rheumatica can coexist.
287. Remitting seronegative symmetrical synovitis with pitting oedema: disease or syndrome?
288. Eosinophilic synovitis. A new entity?
289. Radiolabelled lymphocyte migration in rheumatoid synovitis.
290. Samarium-153-particulate hydroxyapatite radiation synovectomy: biodistribution data for chronic knee synovitis.
291. Role of endothelium in chronic inflammatory synovitis.
292. Massive eosinophilic synovitis and reactive arthritis associated with filarial infection.
293. Evidence for a viral aetiology of transient synovitis of the hip.
294. Expression of CD69 antigen on synovial fluid T cells in patients with rheumatoid arthritis and other chronic synovitis.
295. Synovial lymphocytes and the aetiology of synovitis.
296. Incidence and management of transient synovitis of the hip: a study in Dutch general practice.
297. Value of unenhanced spin-echo MR imaging in distinguishing between synovitis and effusion of the knee.
298. Pigmented villonodular synovitis.
299. Vascular endothelium, cytokines, and the pathogenesis of inflammatory synovitis.
300. Diffuse pigmented villonodular synovitis: non-surgical management.
301. Ultrasonography in transient synovitis and early Perthes' disease.
302. Immunohistochemical demonstration of CD23 expression on lymphocytes in rheumatoid synovitis.
303. A pathological role for damaged hyaluronan in synovitis.
304. Expression of decay-accelerating factor is reduced on hyperplastic synovial lining cells in rheumatoid synovitis.
305. Hypoxia and inflammatory synovitis: observations and speculation.
306. Pigmented villonodular synovitis.
307. Osteomyelitis and synovitis produced by Mycobacterium marinum in a fisherman.
308. Ultrasound-guided aspiration for transient synovitis of the hip.
309. Is there an allergic synovitis?
310. Plant thorn synovitis. Resolution following total synovectomy.
311. Date palm thorn synovitis.
312. Pigmented villonodular synovitis.
313. Rarity of synovitis in polymyalgia rheumatica.
314. Qualitative and quantitative expression of VHI associated cross reactive idiotopes within IgM rheumatoid factor from patients with early synovitis.
315. Pigmented villonodular synovitis containing coarse calcifications.
316. Treatment of pigmented villonodular synovitis of the knee with yttrium-90 silicate: prospective evaluations by arthroscopy, histology, and 99mTc pertechnetate uptake measurements.
317. Oxygen free radicals, inflammation, and synovitis: and synovitis: the current status.
318. Scintimetric assessment of synovitis activity.
319. Chronic synovitis of the shoulder in familial Mediterranean fever: a disease of symptoms not signs.
320. Imaging of pigmented villonodular synovitis with emphasis on MR imaging.
321. Immunohistological features of synovitis in ankylosing spondylitis: a comparison with rheumatoid arthritis.
322. Scintimetric assessment of synovitis activity during treatment with disease modifying antirheumatic drugs.
323. Cytokines in chronic inflammatory arthritis. I. Failure to detect T cell lymphokines (interleukin 2 and interleukin 3) and presence of macrophage colony-stimulating factor (CSF-1) and a novel mast cell growth factor in rheumatoid synovitis.
324. Use of single photon emission computed tomography (SPECT) to study the distribution of 90Y in patients with Baker's cysts and persistent synovitis of the knee.
325. Severe Synovitis in Two Horses due to the Use of Irrigating Solutions Containing Methanol and Formaldehyde.
326. Structural characteristics of articular cartilage proteoglycan in IgG induced experimental immune synovitis.
327. The synovial membrane of healthy individuals--immunohistochemical overlap with synovitis.
328. Thorn-induced synovitis.
329. Macrophage ferritin and iron deposition in the rat air pouch model of inflammatory synovitis.
330. Transient synovitis of the hip. Its incidence, epidemiology and relation to Perthes' disease.
331. Sonography and joint pressure in synovitis of the adult hip.
332. Epitopes of proteoglycans eliciting an anti-proteoglycan response in chronic immune synovitis.
333. The influence of joint posture on intra-articular pressure. A study of transient synovitis and Perthes' disease.
334. Transient synovitis and Perthes' disease. Is there an aetiological connection?
335. Is chronic synovitis an example of reperfusion injury?
336. Synovitis associated with serum IgM rheumatoid factor arising spontaneously in 'Old English' rabbits.
337. Interferon system in acute transient synovitis.
338. Torsion of localised pigmented villonodular synovitis of the knee.
339. The immune response to pertussis in the 6-day air pouch: a model of chronic synovitis.
340. Cellular immunohistopathology of acute, subacute, and chronic synovitis in rheumatoid arthritis.
341. Fine specificity of serum anticollagen molecules in experimental immune synovitis.
342. Acute synovitis with intra-articular apatite deposits in an osteoarthritic metacarpophalangeal joint.
343. Effect of intravenous iron dextran on rheumatoid synovitis.
344. Synovitis with non-specific histological changes in synovium in chronic sarcoidosis.
345. Acute synovitis caused by an organism of the Rhodochrous taxon.
346. Pigmented villonodular synovitis of the shoulder: radiologic-pathologic assessment.
347. Pigmented villonodular synovitis of synovial joints: clinical, pathologic, and radiologic features.
348. Starch synovitis.
349. IgG-induced experimental immune synovitis: hormonal modulation of in vitro splenic immune responses to homologous antigens.
350. Fibre glass induced synovitis.
351. Eosinophilic transient synovitis.
352. Recurrences of transient synovitis of the hip.
353. Rheumatoid arthritis developing after plant thorn synovitis.
354. Subcutaneous nodular synovitis following medial arthrotomy in a case of myxoid liposarcoma of the thigh.
355. Arthrosonography in the diagnosis of pigmented villonodular synovitis.
356. Rheumatoid knee synovitis successfully treated with intra-articular rifamycin SV.
357. Traumatic synovitis in a classical guitarist: a study of joint laxity.
358. Chronic sarcoid synovitis in the Caucasian: an arthroscopic and histological study.
359. Polyarticular pigmented villonodular synovitis.
360. IgG rheumatoid factor, complement and immune complexes in rheumatoid synovitis and vasculitis: comparative and serial studies during cytotoxic therapy.
361. Pigmented villonodular synovitis: correlation of angiographic and histologic findings.
362. An objective assessment of synovitis of the knee: measurement of the size of the suprapatellar pouch on xeroradiography.
363. Infrapatellar pigmented villonodular synovitis: arthrographic detection.
364. Metabolic alterations in human synovial lining cells in pigmented villonodular synovitis.
365. An evaluation of repeat intra-articular injections of yttrium-90 colloids in persistent synovitis of the knee.
366. Subclasses IgA1 and IgA2 in serum and synovial fluid in rheumatoid arthritis and reactive synovitis of local origin.
367. A thermographic assessment of three intra-articular prednisolone analogues given in rheumatoid synovitis.
368. Immune synovitis in rabbits. Effects of differing schedules for intra-articular challenge with antigen.
369. Chronic synovitis with early cartilage destruction in sickle cell disease.
370. New models of chronic synovitis in rabbits induced by mycoplasmas: microbiological, histopathological, and immunological observations on rabbits injected with Mycoplasma arthritidis and Mycoplasma pulmonis.
371. Localized nodular synovitis of the knee: a report of two cases with abnormal arthrograms.
372. A cause of erroneous diagnosis of pigmented villonodular synovitis.
373. Pigmented villonodular synovitis in multiple joints. Occurrence in a child with cavernous haemangioma of lip and pulmonary stenosis.
374. Chronic monarticular synovitis. Diagnostic and prognostic features.
375. Rheumatoid synovitis and joint disease. Relationship between arthroscopic and histological changes.
376. B- and T-lymphocytes in rheumatoid synovitis and the effect of cyclophosphamide.
377. Enhancement activity of homologous anti-staphylococcal sera in experimental staphylococcal synovitis of chicks: a possible role of immune adherence antibodies.
378. Antigen retention in joint tissues in antigen-induced synovitis.
379. Use of yttrium 90 in persistent synovitis of the knee. II. Direct comparison of yttrium colloid resin and yttrium citrate.
380. Effects of intra-articular corticosteroids in vivo on synovial fluid variables in rheumatoid synovitis.
381. Early studies of (198)Au in the treatment of synovitis of the knee.
382. Transient synovitis in Perthes's disease.
383. Role of thymic and bursal lymphocyte subclasses in chronic allergic synovitis in the chicken.
384. Use of yttrium 90 in persistent synovitis of the knee. I. Retention in the knee and spread in the body after injection.
385. Arthus synovitis with horseradish peroxidase as antigen: sequential participation of platelets and leucocytes.
386. Immunoglobulins A, G, and M in synovial fluid in rheumatoid arthritis. Reactive synovitis of local origin and in post mortem synovial fluid.
387. Effect of iron dextran, gold thiosulphate, and hydrocortisone acetate on experimental synovitis in the guinea pig.
388. Articular scanning and external counting in experimental synovitis in the guinea-pig.
389. Surgical synovectomy and experimental immune synovitis in the rabbit knee joint.
390. Immune complexes in rheumatoid synovitis: a mixed staining immunofluorescence study.
391. The etiology of transient synovitis of the hip in childhood.
392. Transient synovitis and Legg-Calvé-Perthes disease: a comparative study.
393. Transient synovitis of the hip.
394. The induction of synovitis in the normal rabbit with Fab. A possible experimental model of rheumatoid arthritis.
395. Transient synovitis of hip. A virological investigation.
396. Pigmented villonodular synovitis of the wrist joint.
397. Bone lesions in pigmented villonodular synovitis.
398. Pigmented villonodular synovitis of the wrist with penetration into bone.
399. The diagnosis and treatment of pigmented villonodular synovitis.
400. Soft tissue inflammations-bursitis-tendinitis-synovitis.
401. Surgery of rheumatoid synovitis of the hand.
402. Suppressive effects of indoxole in crystal-induced synovitis in man.
403. Acute calcific synovitis of the knee.
404. Crystal synovitis.
405. EXPERIMENTAL PRODUCTION OF SYNOVITIS AND MARGINAL ARTICULAR EXOSTOSES IN THE KNEE JOINTS OF DOGS.
406. TRANSITORY SYNOVITIS OF THE HIP IN CHILDREN.
407. RUBELLA SYNOVITIS.
408. RUBELLA SYNOVITIS.
409. Preparation of antigen and antiserum for the infectious synovitis-type pleuropneumonia-like organisms.
410. Pigmented Villonodular Synovitis with Invasion of Bone.
411. Isolation of a species of genus Herellea from a patient with acute synovitis.
412. Recurrent synovitis of the knee.
413. A Suspected Case Of Infectious Synovitis In Alberta.
414. Experimental production of pigmented villonodular synovitis in dogs.
415. TRAUMATIC SYNOVITIS AND INJURIES TO THE LIGAMENTS OF THE KNEE-JOINT.
416. Synovectomy of Knee for Chronic Synovitis Following Trauma.
417. Synovectomy of Knee for Chronic non-traumatic Synovitis.
418. Chronic Synovitis of the Left Knee-joint.
419. A Case of Gonococcic Synovitis.
420. Chronic Painless Synovitis of Knee associated with Bazin's Disease.
421. A Case of Symmetrical Synovitis of Knees.
422. TRAUMATIC SYNOVITIS OF THE KNEE, ACUTE AND CHRONIC: A Review of the Literature.
423. TREATMENT OF TRAUMATIC SYNOVITIS.
424. THE EFFICIENT TREATMENT OF ACUTE AND CHRONIC, SIMPLE, TRAUMATIC SYNOVITIS (HAEMARTHROSES AND HYDARTHROSES) BY REPEATED ASPIRATIONS AND IMMEDIATE, ACTIVE MOBILIZATIONS WITHOUT SPLINTING.
425. TREATMENT OF CHRONIC SYNOVITIS OF THE KNEE-JOINT.
426. TREATMENT BY INFLATION WITH OXYGEN OF TUBERCULOUS AFFECTIONS OF THE ENCLOSED CAVITIES, ABSCESSES, CARIES, SYNOVITIS, AND FIBROUS ANKYLOSIS.
427. Case of Chronic Synovitis of both Knee-joints.
428. Synovitis of Hands, Feet, and Knees, in a Congenital Syphilitic.
429. Sporotrichosis of the Disseminated, Ulcerating, Gumma Type, in which there occurred Acute Synovitis.
430. Tertiary Syphilis (Gummatous Teno-synovitis).
431. Tuberculous Synovitis of Knee-joint in which Arthrectomy was performed on Two Occasions, a Movable Joint Resulting.
432. THE DIAGNOSIS AND TREATMENT OF VARIOUS FORMS OF SEPTIC SYNOVITIS.
433. Remarks on Cases of Multiple Synovitis, following Injuries to Joints.
434. Clinical Lecture on Acute Synovitis and Traumatic Aneurism.